Seeing patients in clinic 10+ years after TIL treatment (long term responders) has been an extremely rewarding part of the immunotherapy fellowship at @NCI_CCR_SB, and a humbling reminder of the potential of adoptive cell therapy
Every month that you neglect your physical health while early in your career, you incur a debt that you will repay later on, when you should be in the prime of your career.
I’ve learned this now but I wish I could have explained this to my 30-year-old self.
Most common med student presentation mistake I see:
The opening sentence when presenting a patient should give the patient’s age, gender and why they are being seen but NOTHING more. Leave the other stuff out until after you orient the listener to why the patient is there.
Good: “53yom here with chest pain” “82yof day 3 post op”
After this you can fill in details and the listener is oriented as you speak.
Bad: “60yom with h/o HTN, diabetes, prior hip fracture, BPH, ED, anxiety, family history of colon CA who now comes in because of chest pain.”
The listener has no idea which parts of that PMH matter most until you say why the patient is being seen.
A wonderful experience to advocate for key healthcare policy reform on The Hill with colleagues and mentors! Thank you @RASACS and @AmCollSurgeons for the opportunity and the Travel Award. #ACSLAS2024@RepJoeMorelle
Congratulations to @tellkrish, and endorsement for all postdocs- you could not ask for a more dedicated mentor, steadfast scientist, or overall beneficial educational experience than working with Dr. Sri Krishna at the @NCI_CCR_SB
Tahsin is one of the hardest workers I have ever met, and extremely well read in both science and surgery. To quote a question from the audience: “how did you fit 10 years of work into a 3 year fellowship?”. A truly excellent talk @TKhan_GS @NCI_SurgOncFel
So fortunate to have had the opportunity to learn from @tellkrish and @franklowery - working so closely with these clinically focused scientists (and dedicated teachers) has been an amazing opportunity at the @NCI_CCR_SB. Thrilled to share this publication!
Colleagues: can we please stop overstating the risk of
1. postop NSAIDs
2. Contrast nephropathy
3. Nephrotenic systemic fibrosis.
Toradol, CT contrast and gadolinium can all be used in patients with CKD.
Excellent talk by @franklowery on a selected molecular signature of neoantigen-reactive T cells (from metastatic human cancer) —> prospective anti tumor TCR prediction! #SITC21@sitcancer @NCIResearchCtr @NCI_CCR_SB
"I'm Not Worried About My Cancer Coming Back" -- Checking In With Judy Perkins, The First Metastatic Breast Cancer Patient To Be Cured With Immunotherapy https://t.co/1kQqU5dQcJ #ThisIsWhy#NothingWillStopUs